Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance

Excess free fatty acids, an imbalance of adipocytokines and mitochondrial dysfunction all contribute to abnormalities in hepatocellular lipid content in diabetes and can lead to steatosis and insulin resistance. Thus liver fat is a novel target for therapies such as fat-reduced diets and thiazoliden...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature clinical practice. Endocrinology & metabolism Ročník 2; číslo 6; s. 335 - 348
Hlavný autor:	Roden, Michael
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 01.06.2006 Nature Publishing Group
Predmet:	Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Endocrinology Fatty acids Fatty Acids, Nonesterified - metabolism Fatty Liver - drug therapy Fatty Liver - etiology Fatty Liver - metabolism Gastroenterology Glucose Humans Hypoglycemic Agents - pharmacology Hypoglycemic Agents - therapeutic use Insulin resistance Insulin Resistance - physiology Kinases Lipids Liver - drug effects Liver - metabolism Liver - pathology Liver cirrhosis Liver diseases Medicine Medicine & Public Health Metabolism Models, Biological Nephrology Nutrients Oils & fats review-article Triglycerides
ISSN:	1745-8366, 1759-5029, 1745-8374, 1759-5037
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!